Barrington Research Brokers Boost Earnings Estimates for Option Care Health, Inc. (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCH - Free Report) - Stock analysts at Barrington Research lifted their FY2024 earnings per share (EPS) estimates for shares of Option Care Health in a research note issued on Wednesday, April 24th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $1.15 for the year, up from their prior forecast of $1.10. Barrington Research currently has a "Outperform" rating and a $38.00 price target on the stock. The consensus estimate for Option Care Health's current full-year earnings is $1.17 per share. Barrington Research also issued estimates for Option Care Health's FY2025 earnings at $1.35 EPS.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.22 by $0.04. The firm had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The business's revenue for the quarter was up 12.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.21 EPS.

Separately, Jefferies Financial Group lifted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "buy" rating in a report on Monday, March 4th.

Option Care Health Stock Up 1.1 %

OPCH traded up $0.32 during mid-day trading on Friday, reaching $29.61. 1,759,662 shares of the stock were exchanged, compared to its average volume of 1,297,141. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. The stock has a market capitalization of $5.15 billion, a PE ratio of 19.48, a price-to-earnings-growth ratio of 1.65 and a beta of 1.22. The company has a 50 day moving average price of $31.96 and a two-hundred day moving average price of $31.48. Option Care Health has a 1 year low of $24.23 and a 1 year high of $35.74.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of the stock in a transaction dated Monday, February 26th. The shares were bought at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the purchase, the director now directly owns 269,528 shares of the company's stock, valued at approximately $8,503,608.40. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 0.64% of the company's stock.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. IFP Advisors Inc raised its stake in Option Care Health by 20,350.0% in the 3rd quarter. IFP Advisors Inc now owns 2,454 shares of the company's stock valued at $79,000 after acquiring an additional 2,442 shares during the period. State of Alaska Department of Revenue raised its stake in Option Care Health by 4.3% in the 3rd quarter. State of Alaska Department of Revenue now owns 21,376 shares of the company's stock valued at $691,000 after acquiring an additional 880 shares during the period. Exchange Traded Concepts LLC bought a new stake in Option Care Health in the 3rd quarter valued at about $812,000. Handelsbanken Fonder AB raised its stake in Option Care Health by 24.3% in the 3rd quarter. Handelsbanken Fonder AB now owns 33,300 shares of the company's stock valued at $1,077,000 after acquiring an additional 6,500 shares during the period. Finally, Sheets Smith Wealth Management raised its stake in Option Care Health by 1.6% in the 3rd quarter. Sheets Smith Wealth Management now owns 32,542 shares of the company's stock valued at $1,053,000 after acquiring an additional 510 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.